Invention Grant
- Patent Title: Methods for purifying FXa variant proteins
-
Application No.: US15669340Application Date: 2017-08-04
-
Publication No.: US10660946B2Publication Date: 2020-05-26
- Inventor: Keith A. Johnson , Jason C. Rouse , Penelope Jane Sharpe , Michael Shamashkin , Wendy Carol Piacenza , Mary Beth Switzer , Stacey B. Weston , Michael Anthony Jankowski
- Applicant: PFIZER INC.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Main IPC: A61K38/48
- IPC: A61K38/48 ; A61K38/36 ; C12N9/64
Abstract:
Compositions are provided comprising recombinant variants of the human clotting Factor Xa. Such compositions include a wide variety of isoforms and post-translational modifications of FXa and are useful for treating subjects in need of hemostasis.
Public/Granted literature
- US20170333535A1 COMPOSITIONS COMPRISING HETEROGENEOUS POPULATIONS OF RECOMBINANT HUMAN CLOTTING FACTOR XA PROTEINS Public/Granted day:2017-11-23
Information query
IPC分类:
